Therapeutic Vaccines Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines, Other Products), By Applications (Allogeneic Vaccine, Autologous Vaccine), and Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Therapeutic Vaccines Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Therapeutic Vaccines Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Therapeutic Vaccines Business Mode and Production Process
2.3.1 Therapeutic Vaccines Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Therapeutic Vaccines Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Therapeutic Vaccines
2.4.2 Raw Material Cost of Therapeutic Vaccines
2.4.3 Labor Cost of Therapeutic Vaccines
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Therapeutic Vaccines Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Therapeutic Vaccines Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Therapeutic Vaccines Price by Manufacturer (2021-2026)
4.4 Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Therapeutic Vaccines, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Therapeutic Vaccines, Product Offered and Application
4.7 Therapeutic Vaccines Market Competitive Situation and Trends
4.7.1 Therapeutic Vaccines Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Therapeutic Vaccines Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Therapeutic Vaccines Market Historical Development by Geographic Region (2021-2026)
5.1 Global Therapeutic Vaccines Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Therapeutic Vaccines Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Therapeutic Vaccines Market Status by Country (2021-2026)
5.3.1 North America Therapeutic Vaccines Sales Volume by Country (2021-2026)
5.3.2 North America Therapeutic Vaccines Revenue by Country (2021-2026)
5.3.3 United States Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Therapeutic Vaccines Market Status by Country (2021-2026)
5.4.1 Europe Therapeutic Vaccines Sales Volume by Country (2021-2026)
5.4.2 Europe Therapeutic Vaccines Revenue by Country (2021-2026)
5.4.3 Germany Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Therapeutic Vaccines Market Status by Country (2021-2026)
5.5.1 Asia Pacific Therapeutic Vaccines Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Therapeutic Vaccines Revenue by Country (2021-2026)
5.5.3 China Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Therapeutic Vaccines Market Status by Country (2021-2026)
5.6.1 Latin America Therapeutic Vaccines Sales Volume by Country (2021-2026)
5.6.2 Latin America Therapeutic Vaccines Revenue by Country (2021-2026)
5.6.3 Mexico Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Therapeutic Vaccines Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Therapeutic Vaccines Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Therapeutic Vaccines Revenue by Country (2021-2026)
5.7.3 GCC Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Therapeutic Vaccines Sales Volume, Revenue and Growth (2021-2026)

6 Global Therapeutic Vaccines Market Historical Development by Product Type (2021-2026)
6.1 Therapeutic Vaccines Definition by Type
6.2 Global Therapeutic Vaccines Historical Sales Volume by Product Type (2021-2026)
6.3 Global Therapeutic Vaccines Historical Revenue by Product Type (2021-2026)
6.4 Global Therapeutic Vaccines Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Autoimmune Disease Vaccines (2021-2026)
6.5.2 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Neurological Disease Vaccines (2021-2026)
6.5.3 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2021-2026)
6.5.4 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Infectious Disease Vaccines (2021-2026)
6.5.5 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Other Products (2021-2026)

7 Global Therapeutic Vaccines Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Therapeutic Vaccines Historical Sales Volume by End User (2021-2026)
7.3 Global Therapeutic Vaccines Historical Revenue by End User (2021-2026)
7.4 Global Therapeutic Vaccines Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Allogeneic Vaccine (2021-2026)
7.5.2 Global Therapeutic Vaccines Historical Sales Volume, Revenue and Growth Rate of Autologous Vaccine (2021-2026)

8 Leading Companies Profiles
8.1 Corixa
8.1.1 Corixa Corporation Information
8.1.2 Corixa - Therapeutic Vaccines Product Portfolio and Specification
8.1.3 Corixa Performance Analysis (2021-2026)
8.1.4 Corixa Business and Markets Served
8.1.5 Corixa Recent Developments
8.2 CIMAB S.A.
8.2.1 CIMAB S.A. Corporation Information
8.2.2 CIMAB S.A. - Therapeutic Vaccines Product Portfolio and Specification
8.2.3 CIMAB S.A. Performance Analysis (2021-2026)
8.2.4 CIMAB S.A. Business and Markets Served
8.2.5 CIMAB S.A. Recent Developments
8.3 Immune Response BioPharma Inc.
8.3.1 Immune Response BioPharma Inc. Corporation Information
8.3.2 Immune Response BioPharma Inc. - Therapeutic Vaccines Product Portfolio and Specification
8.3.3 Immune Response BioPharma Inc. Performance Analysis (2021-2026)
8.3.4 Immune Response BioPharma Inc. Business and Markets Served
8.3.5 Immune Response BioPharma Inc. Recent Developments
8.4 Aimmune Therapeutics Inc.
8.4.1 Aimmune Therapeutics Inc. Corporation Information
8.4.2 Aimmune Therapeutics Inc. - Therapeutic Vaccines Product Portfolio and Specification
8.4.3 Aimmune Therapeutics Inc. Performance Analysis (2021-2026)
8.4.4 Aimmune Therapeutics Inc. Business and Markets Served
8.4.5 Aimmune Therapeutics Inc. Recent Developments
8.5 Sanpower Group Co. Ltd.
8.5.1 Sanpower Group Co. Ltd. Corporation Information
8.5.2 Sanpower Group Co. Ltd. - Therapeutic Vaccines Product Portfolio and Specification
8.5.3 Sanpower Group Co. Ltd. Performance Analysis (2021-2026)
8.5.4 Sanpower Group Co. Ltd. Business and Markets Served
8.5.5 Sanpower Group Co. Ltd. Recent Developments
8.6 Inovio Pharmaceuticals Inc.
8.6.1 Inovio Pharmaceuticals Inc. Corporation Information
8.6.2 Inovio Pharmaceuticals Inc. - Therapeutic Vaccines Product Portfolio and Specification
8.6.3 Inovio Pharmaceuticals Inc. Performance Analysis (2021-2026)
8.6.4 Inovio Pharmaceuticals Inc. Business and Markets Served
8.6.5 Inovio Pharmaceuticals Inc. Recent Developments
8.7 Vaccinogen, Inc.
8.7.1 Vaccinogen, Inc. Corporation Information
8.7.2 Vaccinogen, Inc. - Therapeutic Vaccines Product Portfolio and Specification
8.7.3 Vaccinogen, Inc. Performance Analysis (2021-2026)
8.7.4 Vaccinogen, Inc. Business and Markets Served
8.7.5 Vaccinogen, Inc. Recent Developments
8.8 Bavarian Nordic
8.8.1 Bavarian Nordic Corporation Information
8.8.2 Bavarian Nordic - Therapeutic Vaccines Product Portfolio and Specification
8.8.3 Bavarian Nordic Performance Analysis (2021-2026)
8.8.4 Bavarian Nordic Business and Markets Served
8.8.5 Bavarian Nordic Recent Developments
8.9 AVAX
8.9.1 AVAX Corporation Information
8.9.2 AVAX - Therapeutic Vaccines Product Portfolio and Specification
8.9.3 AVAX Performance Analysis (2021-2026)
8.9.4 AVAX Business and Markets Served
8.9.5 AVAX Recent Developments
8.10 GlaxoSmithKline plc.
8.10.1 GlaxoSmithKline plc. Corporation Information
8.10.2 GlaxoSmithKline plc. - Therapeutic Vaccines Product Portfolio and Specification
8.10.3 GlaxoSmithKline plc. Performance Analysis (2021-2026)
8.10.4 GlaxoSmithKline plc. Business and Markets Served
8.10.5 GlaxoSmithKline plc. Recent Developments
8.11 Galena Biopharma
8.11.1 Galena Biopharma Corporation Information
8.11.2 Galena Biopharma - Therapeutic Vaccines Product Portfolio and Specification
8.11.3 Galena Biopharma Performance Analysis (2021-2026)
8.11.4 Galena Biopharma Business and Markets Served
8.11.5 Galena Biopharma Recent Developments
8.12 Pfizer Inc.
8.12.1 Pfizer Inc. Corporation Information
8.12.2 Pfizer Inc. - Therapeutic Vaccines Product Portfolio and Specification
8.12.3 Pfizer Inc. Performance Analysis (2021-2026)
8.12.4 Pfizer Inc. Business and Markets Served
8.12.5 Pfizer Inc. Recent Developments
8.13 Agenus Inc.
8.13.1 Agenus Inc. Corporation Information
8.13.2 Agenus Inc. - Therapeutic Vaccines Product Portfolio and Specification
8.13.3 Agenus Inc. Performance Analysis (2021-2026)
8.13.4 Agenus Inc. Business and Markets Served
8.13.5 Agenus Inc. Recent Developments
8.14 Novartis AG
8.14.1 Novartis AG Corporation Information
8.14.2 Novartis AG - Therapeutic Vaccines Product Portfolio and Specification
8.14.3 Novartis AG Performance Analysis (2021-2026)
8.14.4 Novartis AG Business and Markets Served
8.14.5 Novartis AG Recent Developments
8.15 Dendreon
8.15.1 Dendreon Corporation Information
8.15.2 Dendreon - Therapeutic Vaccines Product Portfolio and Specification
8.15.3 Dendreon Performance Analysis (2021-2026)
8.15.4 Dendreon Business and Markets Served
8.15.5 Dendreon Recent Developments
8.16 Northwest Biotherapeutics
8.16.1 Northwest Biotherapeutics Corporation Information
8.16.2 Northwest Biotherapeutics - Therapeutic Vaccines Product Portfolio and Specification
8.16.3 Northwest Biotherapeutics Performance Analysis (2021-2026)
8.16.4 Northwest Biotherapeutics Business and Markets Served
8.16.5 Northwest Biotherapeutics Recent Developments
8.17 Argos Therapeutics
8.17.1 Argos Therapeutics Corporation Information
8.17.2 Argos Therapeutics - Therapeutic Vaccines Product Portfolio and Specification
8.17.3 Argos Therapeutics Performance Analysis (2021-2026)
8.17.4 Argos Therapeutics Business and Markets Served
8.17.5 Argos Therapeutics Recent Developments

9 Global Therapeutic Vaccines Market Forecast by Product Type and End User (2026-2035)
9.1 Global Therapeutic Vaccines Market Forecast by Product Type (2026-2035)
9.1.1 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Autoimmune Disease Vaccines (2026-2035)
9.1.2 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Neurological Disease Vaccines (2026-2035)
9.1.3 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Cancer Vaccines (2026-2035)
9.1.4 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Infectious Disease Vaccines (2026-2035)
9.1.5 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Other Products (2026-2035)
9.2 Global Therapeutic Vaccines Market Forecast by End User (2026-2035)
9.2.1 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Allogeneic Vaccine (2026-2035)
9.2.2 Global Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth Rate of Autologous Vaccine (2026-2035)

10 Global Therapeutic Vaccines Market Forecast by Geographic Region (2026-2035)
10.1 Global Therapeutic Vaccines Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Therapeutic Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer